Europe Hypodermics Market To Reach $936.0 Million By 2030

Europe Hypodermics Market Growth & Trends

The Europe hypodermics market size is anticipated to reach USD 936.0 million by 2030 and is anticipated to grow at a CAGR of 13.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases, number of vaccination programs, and increasing number of needlestick injuries are expected to increase the demand for hypodermics in the coming decade.

Government-sponsored initiatives and campaigns for preventing several infectious diseases are anticipated to augment the market growth. In June 2024, Finland offered vaccination against bird flu to individuals working with poultry or on fur farms. Rapidly increasing geriatric population and prevalence of chronic diseases leads to an increase in hospital admissions or medical treatments. Thus, the increasing necessity of hypodermics is resulting in market growth. The number of diabetes cases is expected to continue to grow, necessitating regular insulin injections and, consequently, a steady demand for hypodermic products. According to Diabetes UK, as of 2022 - 23, there are over 5.6 million people in the UK living with diabetes.

 Request a free sample copy or view report summary: Europe Hypodermics Market Report

Europe Hypodermics Market Report Highlights

• Hypodermic syringes dominated the product segment with more than 60.0% share in 2023 owing to the prevalence of chronic conditions leading to a higher demand for hypodermic syringes.

• The hypodermic needles segment is expected to grow at the fastest CAGR over the forecast period.

• Growing demand for vaccinations, safer needle designs, and increasing innovations to reduce pain are contributing to the growing adoption of hypodermic needles and syringes.

• The hospitals segment dominated the market in 2023. Hospitals influence the hypodermics market by generating a high and steady demand for hypodermic needles & syringes due to the large volume of medical procedures performed.

• Homecare is expected to grow at the fastest CAGR over the forecast period and can be attributed to the increasing prevalence of chronic diseases and the growing preference for managing health conditions at home.

• The Ambulatory Surgical Centers (ASCs) segment is expected to grow rapidly during the forecast period due to the high number of outpatient surgical procedures performed in these settings. ASCs provide a wide range of surgical services that require the use of hypodermic products for tasks such as administering local anesthesia, intravenous medications, and postoperative care.

• UK dominated the Europe market in 2023 owing to factors such as the increasing prevalence of cancer, rapidly aging population, proactive government initiatives for immunization and adoption of safety-engineered hypodermic needles.

Europe Hypodermics Market Segmentation

Grand View Research has segmented the Europe hypodermics market based on product, end-use, and country:

Europe Hypodermics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Hypodermic Needles

  • Conventional Needles

  • Safety Needles

• Hypodermic Syringes

  • Conventional Syringes

  • Safety Syringes

    • Retractable Safety Syringes

    • Non-retractable Safety Syringes

Europe Hypodermics End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Ambulatory Surgical Centers

• Veterinary

• Home Care

• Others

Europe Hypodermics Country Outlook (Revenue, USD Million; 2018 - 2030)

• U.K.

• Ireland

• Denmark

• Finland

• Iceland

• Norway

• Sweden

• Kuwait

List of Key Players in the Europe Hypodermics Market

• BD (Becton, Dickinson & Corporation)

• Cardinal Health

• B. Braun SE

• ICU Medical

• Terumo Corporation

• Nipro Europe Group Companies (Nipro Corporation)

• SolM

• GBUK Group Ltd.

• Troge Medical GmbH

• Secured Medical Direction UK Co., Ltd.